Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 3

Фенотипы бронхиальной астмы у детей: от диагностики к лечению
С.В. Зайцева, А.К. Застрожина, О.В. Зайцева, С.Ю. Снитко

References
1. Mallola J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A; ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a global synthesis. Allergollogia et Immunopathologia (Madr) 2013 Mar-Apr;41(2):73-85.
2. Zaytseva SV. Bronchial asthma in children: efficacy evaluation and treatment optimization [dissertation for the Degree of Candidate of Medical Sciences]. Moscow, 2001; 161 p. (In Russian).
3. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2018. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2018-GINA.pdf Accessed 2018 Dec 12.
4. Russian Respiratory Society, Pediatric Respiratory Society, Federation of Pediatricians of the CIS Countries. Bronchial asthma in children. National treatment and prevention program. 5th ed. Moscow; Original-Maket; 2017. 160 p. (In Russian).
5. Nenasheva NM. Asthma phenotypes and therapy choice. Practical Pulmonology 2014;2:2-11 (In Russian).
6. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nature Reviews. Immunology 2008 Mar;8(3):169-82.
7. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008 Sep;372(9643):1107-19.
8. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, Helms PJ, Hunt J, Liu A, Papadopoulos N, Platts-Mills T, Pohunek P, Simons FE, Valovirta E, Wahn U, Wildhaber J; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008 Jan;63(1):5-34.
9. Boner AL, Martinati LC. Diagnosis of asthma in children and adolescents. European Respiratory Review 1997;7:3-7.
10. Kobzev DYu, Udovichenko EN, Perfilova IA, Gamova IV, Astafyeva NG. Difficulties in asthma diagnosis and treatment in children under 5. Lechashchiy Vrach 2011;1:1-8 (In Russian).
11. Kiley J, Smith R, Noel P. Asthma phenotypes. Current Opinion in Pulmonary Medicine 2007 Jan;13(1):19-23.
12. Taussig LM, Wright AL, Holberg Нalonen M, Morgan WJ, Martinez FD. Tucson Children’s Respiratory Study: 1980 to present. The Journal of Allergy and Clinical Immunology 2003 Apr;111(4):661-75.
13. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The New England Journal of Medicine 1995 Jan;332(3):133-8.
14. Berry CE, Billheimer D, Jenkins IC, Lu ZJ, Stern DA, Gerald LB, Carr TF, Guerra S, Morgan WJ, Wright AL, Martinez FD. A distinct low lung function trajectory from childhood to the fourth decade of life. American Journal of Respiratory and Critical Care Medicine 2016 Sep;194(5):607-12.
15. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, Zar H, Akdis CA, Bacharier LB, Baraldi E, van Bever HP, de Blic J, Boner A, Burks W, Casale TB, Castro-Rodriguez JA, Chen YZ, El-Gamal YM, Everard ML, Frischer T, Geller M, Gereda J, Goh DY, Guilbert TW, Hedlin G, Heymann PW, Hong SJ, Hossny EM, Huang JL, Jackson DJ, de Jongste JC, Kalayci O, Aït-Khaled N, Kling S, Kuna P, Lau S, Ledford DK, Lee SI, Liu AH, Lockey RF, Lødrup-Carlsen K, Lötvall J, Morikawa A, Nieto A, Paramesh H, Pawankar R, Pohunek P, Pongracic J, Price D, Robertson C, Rosario N, Rossenwasser LJ, Sly PD, Stein R, Stick S, Szefler S, Taussig LM, Valovirta E, Vichyanond P, Wallace D, Weinberg E, Wennergren G, Wildhaber J, Zeiger RS. International consensus on (ICON) pediatric asthma. Allergy 2012 Aug;67(8):976-97.
16. Ovsyannikov DYu, Bolibok AM, Khaled M, Kravchuk DA, Larina VN, Nazarova VV, Korobyants EA. Heterogeneity of bronchial obstruction and asthma in children: diagnostic difficulties. Difficult Patient 2017;15(1-2):43-52 (In Russian).
17. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnson R, Gustafsson PM. Asthma and allergy patterns over 18 years after severe RSV-bronchiolitis in the first year of life. Thorax 2010 Dec;65(12):1045-52.
18. Bezemer GF, Sagar S, van Bergenhenegouwen J, Georgiou NA, Garssen J, Kraneveld AD, Folkerts G. Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease. Pharmacological Reviews 2012;64:337-58.
19. Zakeri A, Yazdi FG. Toll-like receptor-mediated involvement of innate immune cells in asthma disease. Biochimica et Biophysica Acta. General Subjects 2017 Jan;1861(1 Pt A):3270-7.
20. Holgate ST. Innate and adaptive immune responses in asthma. Nature Medicine 2012 May;18(5):673-83.
21. Mantzouranis E, Papadopouli E, Michailidi E. Childhood asthma: recent developments and update. Current Opinion in Pulmonary Medicine 2014 Jan;20(1):8-16.
22. Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Current Opinion in Immunology 2004 Dec;16(6):702-8.
23. Gushchin IS, Kurbacheva OM. Allergy and allergen-specific immunotherapy. Moscow: Farmarus Print Media; 2010. 228 p. (In Russian).
24. Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Frontiers in Microbiology 2013;4:263.
25. Lambrecht BN, Hammad H. The immunology of asthma. Nature Immunology 2014 Jan;16(1):45-56.
26. Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. The Journal of Allergy and Clinical Immunology 1996 Jul;98(1):1-13.
27. Novik GA. Antileukotrienes in the treatment of allergic rhinitis. Lechashchiy Vrach 2014;3:75-82 (In Russian).
28. Liu M, Yokomizo T. The role of leukotrienes in allergic diseases. Allergology International 2015 Jan;64(1):17-26.
29. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, Brockow K, Campo P, Celik G, Cernadas J, Cortellini G, Gomes E, Niżankowska-Mogilnicka E, Romano A, Szczeklik A, Testi S, Torres MJ, Wöhrl S, Makowska J. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013 Oct;68(10):1219-32.
30. Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. The Journal of Allergy and Clinical Immunology 2015 Mar;135(3):676-81.e1.
31. Ertoy Karagol HI, Yilmaz O, Topal E, Ceylan A, Bakirtas A. Nonsteroidal anti-inflammatory drugs – exacerbated respiratory disease in adolescents. International Forum of Allergy & Rhinology 2015 Mar;5(5):392-8.
32. Ameratunga R, Randall N, Dalziel S, Anderson BJ. Samter’s triad in childhood: a warning for those prescribing NSAIDs. Paediatric Anaesthesia 2013 Aug;23(8):757-9.
33. Debley JS, Carter ER, Gibson RL, Rosenfeld M, Redding GJ. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. The Journal of Pediatrics 2005 Aug;147(2):233-8.
34. Sih K, Goldman RD. Nonsteroidal anti-inflammatory drug administration in children with history of wheeze. Canadian Family Physician 2016 Aug;62(8):633-4.
35. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske RF Jr, Wardlaw AJ, Wenzel SE, Greenberger PA. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. The Journal of Allergy and Clinical Immunology 2011 Feb;127(2):355-60.
36. Shostak NA, Klimenko AA. NSAIDs: current aspects of their application. The Clinician 2013;3-4:53-61 (In Russian).
37. Vorzheva II. Aspirin-induced asthma: clinical features and diagnosis. Practical Pulmonology 2015;1:2-12 (In Russian).
38. Bergmann KC, Zuberbier T, Church MK. Omalizumab in the treatment of aspirin-exacerbated respiratory disease. The Journal of Allergy and Clinical Immunology: in Practice 2015 May-Jun;3(3):459-60.
39. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, De Ruyck N, Blomme K, Sousa AR, Marshall RP, Bachert C. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. The Journal of Allergy and Clinical Immunology 2011 Nov;128(5):989-95.e1-8.
40. Zedan MM, Laimon WN, Osman AM, Zedan MM. Clinical asthma phenotyping: a trial for bridging gaps in asthma management. World Journal of Clinical Pediatrics 2015 May;4(2):13-8.
41. Kemp JP, Dockhorn RJ, Shapiro GG, Nguyen HH, Reiss TF, Seidenberg BC, Knorr B. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6-to 14-year-old children with asthma. The Journal of Pediatrics 1998 Sep;133(3):424-8.
42. Jeffery PK. The roles of leukotrienes and the effects of leukotriene receptor antagonists in the inflammatory response and remodelling of allergic asthma. Clinical and Experimental Allergy Reviews 2001 Jul;1(2):148-53.
43. Lee DK, Haggart K, Robb FM, Lipworth BJ. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. The European Respiratory Journal 2004 Aug;24(2):226-30.
44. Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine 2002 Jan;165(1):9-14.
45. Fey C, Thyroff-Friesinger U, Jones S. Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults. Clinical and Translational Allergy 2014 Sep;4:29.
46. Montelar® drug instructions. Available from: https://www.sandoz.ru/products/montelar#ui-id-1=7 Accessed 2018 Dec 21 (In Russian).
47. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. American Journal of Respiratory and Critical Care Medicine 2005 Feb 15;171(4):315-22.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]